Medical Acoustics LLC, a commercial-stage medical device company which employs acoustic technologies for diagnostic and therapeutic medical applications, today announced that it has been awarded a UB CAT/NYSTAR grant. The $75,000 grant, which was awarded by the University at Buffalo Center for Advanced Biomedical and Bioengineering Technology (UB CAT) and is funded by the New York State Foundation for Science Technology and Innovation (NYSTAR), will help finance a clinical trial entitled, "Six Month Clinical Trial of Lung Flute® in Patients with COPD". The total cost of the study is expected to be approximately $250,000.
“This extensive clinical study will further demonstrate the health benefits of using the Lung Flute as part of daily Bronchial Hygiene Therapy”
The trial builds on data and feedback gathered over the last year. The Primary Outcome Measure is to evaluate the change in chronic obstructive pulmonary disease (COPD) symptoms assessed by the Clinical COPD Questionnaire (CCQ) between the intervention and control group. Details of the study can be found at www.clinicaltrials.gov/lungflute.
"This extensive clinical study will further demonstrate the health benefits of using the Lung Flute as part of daily Bronchial Hygiene Therapy," commented Nicolaas Smit PhD, Vice President of Science and Technology at Medical Acoustics.
The Lung Flute® is a non-invasive medical device that uses patented low-frequency acoustic wave technology to stimulate the body's natural mucus-clearing system. The device has been cleared by the FDA for therapeutic and diagnostic use in individuals with COPD and other respiratory diseases.
According to the National Heart Lung and Blood Institute, more than 12 million Americans are diagnosed with COPD and an additional 12 million probably have the disease and don't know it. Individuals with COPD suffer from impaired airways and experience a build-up of mucus deep in their lungs, which is difficult to clear and, if left untreated, can lead to bacterial infections. The Lung Flute® helps to dislodge mucus, making it easier for patients to breathe and reducing the likelihood of developing pneumonia or other respiratory ailments.